Clinical follow-up in endovascular treatment for TASC C-D lesions in femoro-popliteal segment

Catheterization and Cardiovascular Interventions

Volumn 73, Issue 5, 2009, Pages 701-705

  Rabellino, Martin ^a,d   Zander, Tobias ^a   Baldi, Sebastian ^a   Nielsen, Luis Garcia ^a   Aragon Sanchez, F Javier ^b   Zerolo, Ignacio ^a   Llorens, Rafael ^a   Maynar, Manuel ^a,b,c  

^a Grupo Hospiten   (Spain)

^b La Paloma Hospital   (Spain)

^c UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^d NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; UROKINASE;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERIOVENOUS FISTULA; ARTERY; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD VESSEL GRAFT; CEREBROVASCULAR ACCIDENT; DISEASE CLASSIFICATION; ECHOGRAPHY; ENDOVASCULAR SURGERY; FALSE ANEURYSM; FEMORAL ARTERY; GRAFT PATENCY; HEART INFARCTION; HEMATOMA; HUMAN; ILIAC ARTERY; INFRAPOPLITEAL ARTERY; INTERMITTENT CLAUDICATION; LIMB AMPUTATION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; POSTOPERATIVE THROMBOSIS; RECANALIZATION; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ANKLE; ARTERIAL OCCLUSIVE DISEASES; BLOOD PRESSURE; BRACHIAL ARTERY; FEMALE; FEMORAL ARTERY; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LOWER EXTREMITY; MALE; MIDDLE AGED; PATIENT SELECTION; POPLITEAL ARTERY; REGISTRIES; SEVERITY OF ILLNESS INDEX; STENTS; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 65549125600     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21971     Document Type: Article

References (30)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45 (Suppl S):S5-S67.
2. Criqui MH, Fronetk A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985;71:510-515.
3. Kannel WB, Skinner J, Jr, Schwartz MJ, Shurtleff D. Intermitent claudication. Incidence in the Framingham Study. Circulation 1970;42:875-883.
4. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survery, 1999-2000. Circulation 2004;110:738-743.
5. Gregg EW, Sorlir P, Pauloseram R, Gu O, Eberhardt MS, Wolz M, Burt V, Curtin L, Engelgau M, Geiss L. Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care 2004;27:1591-1597.
6. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care 2003;26:1435-1438.
7. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, at al. Meta-analysis: Glycosylated hemoglobinand cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-431.
8. Conrad MF, Cambria RP, Stone DH, Brewster DC, Kwolek CJ, Watkins MT, Chung TK, La Muraglia GM. Intermediate result of percutaneous endovascular therapy of femoropopliteal occlusive disease: A contemporary series. J Vasc Surg 2006;44:762-769.
9. DeRubertis BG, Pierce M, Chaer RA, Rhee SJ, Benjeloun R, Ryer EJ, Kent C, Faries PL. Lesion severity and treatment complexity are associated with outcome after percutaneous infrainguinal intervention. J Vasc Surg 2007;46:709-716.
10. Nolan B, Finlayson S, Tosteson A, Powell R, Cronenwett J. The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease-Decision analysis. J Vasc Surg 2007;45:1179-1184.
11. Wholey MH, Maynar MA, Pulido-Duque JM, Reyes R, Jarmolowski CR, Castaneda WR. Comparison of thrombolytic therapy of lower-extremity acute, subacute, and chronic arterial occlusions. Cathet Cardiovasc Diagn 1998;44:159-169.
12. Rutherford FB, Baker JD, Ernst C, Johnston KW, Porter JM, Anh S, et al. Recommended standards for reports dealing with lower extremity ischemia: Revised version. J Vasc Surg 1997; 26:517-538.
13. TASC Working Group. Management of peripheral arterial disease (PAD): Transatlantic Inter-Society Consensus (TASC). Eur J Vasc Endovasc Surg 2000;19:S1-S244.
14. Klinkert P, Schepers A, Burger D, et al. Vein versus polytetra-fluoroethylene in above-knee femoropopliteal by pass grafting: Five years results of a randomized controlled trials. J Vasc Surg 2003;37:149-158.
15. Tilanus HW, Obetrop H, Van Urk H. Saphenous vein or PTFE for femoropopliteal by pass: A prospective rendomized trial. Ann Surg 1985;202:780-782.
16. Pereira CE, Albers M, Romiti M, Brochado-Neto FC, Pereira CA. Meta-analysis of femoropoliteal bypass grafos for coger extremity arterial insufficiency. J Vasc Surg 2006;44:510-517.
17. Griffthis GD, Nagy J, Black D, Stonebridge PA. Randomized clinical trial of distal anastomotic interposition vein cuff in infrainguinal poly-tetrafluoroethylene bypass grafting. Br J Surg 2004;91:560-562.
18. Stonebridge PA, Prescott RJ, Ruckley CV. Randomized trial comparing infrainguinal polytetrafluoroethylene bypass grafting with and without vein interposition cuff at the distal anastomosis. J Vasc Surg 1997;26:543-550.
19. Surowiec SM, Davies MG, Eberly SW, Rhodes JM, Illig KA, Shortell CK, Lee DE, Waldman DL, Green RM. Percutaneous angioplasty and stenting of de superficial femoral artery. J Vasc Surg 2005;41:269-278.
20. Markose G, Bolia A. Subintimal angioplasty in the management of lower limb ischemia. J Cardiovasc Surg 2006;47:399-406.
21. Lazaris AM, Salas C, Tsiamis AC, Vlachou PA, Bolia A, Fishwick G, Bell PR. Factors affecting patency of subintimal infrainguinal angioplasty in patients with critical lower limb ischemia. Eur J Vasc Endovasc Surg 2006;32:668-674.
22. Tang GL, Morasch MD. Role of Stents, Drug-Eluting Stents, and Stent-Grafts in Treatment of Infrainguinal Arterial Disease. Semin Vasc Surg 2007;20:37-41.
23. Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg 2007;45:10-16.
24. Fischer M, Schwabe C, Schulte KL. Value of the hemobahn/viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. J Endovasc Ther 2006;13:281-290.
25. Maynar M, Reyes R, Ferral H, Gorriz E, Gomez-Toledo F, de Blas M, Hubbert T, Castañeda-Zuñiga WR. Cragg Endopro System I: Early experience. I. Femoral arteries. J Vasc Interv Radiol 1997;8:203-207.
26. Scheinert D, Scheinert S, Sax J, Piorkowski C, Braunlich S, Ulrich M, Biamino G, Shmidt A. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-315.
27. Jibegard L, Holm J, Schersten T. Acute limb ischemia due to arterial embolism or thrombosis: Influence of limb ischemia versus pre-existing cardiac disease on postoperative mortality rate. J Cardiovasc Surg 1998;29:32-36.
28. L Italien GJ, Cmabria RP, Cutler BS, Leppo JA, Paul SD, Brewster DC, Hendel RC, Abbott WM, Eagle KA. Comparative early and late cardiac morbidity among patients requiring different vascular surgery procedures. J Vasc Surg 1995;21:935-944.
29. Goshima KR, Mills JL, Sr, Hughes JD. A new look at outcomes after infrainguinal bypass surgery: Traditional reporting standards systematically underestimate the expenditure of effort required to attain limb salvage. J Vasc Surg 2004;39:330-335.
30. Wilson SE, White GH, Wolf G, Cross AP. Proximal percutaneous balloon angioplasty and distal bypass for multilevel arterial occlusion. Ann Vasc Surg 1990;4:351-355.